Benjamin Graham fit · Defensive deep-value investing
Is Vera Therapeutics, Inc. Class A Common Stock (VERA) a Benjamin Graham Stock?
Meets only 4/7 Graham criteria — likely overpriced or unstable.
20/100
FNot a fit
4/7 criteria passed
Benjamin Graham's Criteria, Applied to VERA
P/E ≤ 15
key—
P/B ≤ 1.5
key0.0x
Current ratio ≥ 2
12.1x
Debt / Equity ≤ 1
0.0x
5y profitable
keyNo
Earnings yield ≥ 7%
-8.1%
Revenue growing
172.2%
How VERA Scores on Other Strategies
Live Financial Snapshot
Market cap
$2.54B
P/E (TTM)
-
ROIC (TTM)
-66.5%
Gross margin
0.0%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is VERA's Benjamin Graham fit score?
VERA scores 20/100 on our Benjamin Graham fit engine — grade F. Meets only 4/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own VERA?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends VERA.
How often is this score updated?
VERA's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends VERA.